CHIRON BEHRING GMBH & CO has a total of 84 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AERAS GLOBAL TB VACCINE FOUNDATION, NATIONWIDE CHILDRENS HOSPITAL and HIPRA LAB SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 13 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | United States | 10 | |
#5 | Canada | 9 | |
#6 | Germany | 6 | |
#7 | Australia | 5 | |
#8 | Ireland | 3 | |
#9 | Brazil | 2 | |
#10 | United Kingdom | 2 | |
#11 | Republic of Korea | 2 | |
#12 | New Zealand | 2 | |
#13 | Portugal | 2 | |
#14 | Finland | 1 | |
#15 | Netherlands | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes | |
#8 | Unspecified technologies | |
#9 | Syringes | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Hundt Erika | 15 |
#2 | Knapp Bernhard | 15 |
#3 | Vorlop Juergen | 14 |
#4 | Frech Christian | 12 |
#5 | Gregersen Jens-Peter | 11 |
#6 | Groener Albrecht | 11 |
#7 | Vorlop Jurgen | 8 |
#8 | Luebben Holger | 7 |
#9 | Domdey Horst | 7 |
#10 | Von Specht Bernd-Ulrich | 6 |
Publication | Filing date | Title |
---|---|---|
GB0601733D0 | Vaccines | |
CA2583221A1 | Combination vaccine | |
GB0514053D0 | Rabies vaccine with reduced antigen dose | |
EP1702636A1 | Syringe accessory device | |
US2005063987A1 | Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use | |
AU2002347030A1 | Cultivation of dispersed mycobacteria | |
DE10144903A1 | Replication of virus in cell cultures, useful for preparing vaccines and diagnostic reagents, where replication of cells and virus is simultaneous | |
DE10012370A1 | Use of oil-in-water emulsion as vaccine adjuvant, particularly for influenza and pneumococcal vaccines, administered at different site from the vaccine | |
DE19847628A1 | Helicobacter pylori vaccine | |
DE19847074C1 | Process for the removal of lipopolysaccharides from aqueous, protein-containing solutions | |
CA2250714A1 | Animal cells and processes for the replication of influenza viruses | |
DE19630390A1 | Proteins, in particular membrane proteins from Helicobacter pylori, their production and use | |
EP0717106A1 | Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins | |
DE4232073A1 | Method for the immunochemical quantification of inactivated, immunoreactive antigens |